Recommendations for the Treatment of Children With Burkitt's Lymphoma

02 Mar 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Burkitt Lymphoma · Enrollment 1000 · Sponsor: French Africa Pediatric Oncology Group

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 02 Mar 2026. The item focuses on Recommendations for the Treatment of Children With Burkitt's Lymphoma. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT04425421

Open Original Source More Feed Items

Related by Condition/Drug

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy

Infectious Disease • 18 May 2026

Mechanisms of First-Line Treatment Resistance in DLBCL

Infectious Disease • 08 May 2026

ClinicalTrialsRelated by Conditionlymphoma

Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity

Infectious Disease • 12 Mar 2026

PLOS ONERelated by Conditionlymphoma

Comparison of dose-adjusted EPOCH-R and R-CHOP in diffuse large B-cell lymphoma with high Ki67 expression: Results from a prospective observational study

Research Highlights • 22 May 2026

ClinicalTrialsRelated by Conditionlymphoma

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Infectious Disease • 05 Feb 2026

BMJ OpenRelated by Conditionlymphoma

Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study

Research Highlights • 11 May 2026

Feed Metadata

Source

ClinicalTrials.gov